Praxis Precision Medicines, Inc. (PRAX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 7.46M | 302K | 357K | 431K | 515K | 468K | 781K |
| Revenue Growth % | - | -100% | -100% | -100% | -100% | 1349.13% | -35.47% | -54.29% | -36.9% | - | - | - |
| Cost of Goods Sold | 39K | 0 | 65.8M | 63.01M | 60.81M | 56.29M | 41.88M | 27.26M | 26.98M | 18.39M | 17.26M | 25.61M |
| COGS % of Revenue | - | - | - | - | - | 754.23% | 13867.88% | 7635.85% | 6260.79% | 3570.49% | 3688.03% | 3279.64% |
| Gross Profit | -39K | 0 | -65.8M | -63.01M | -60.81M | -48.83M | -41.58M | -26.9M | -26.55M | -17.87M | -16.79M | -24.83M |
| Gross Margin % | - | - | - | - | - | -654.23% | -13767.88% | -7535.85% | -6160.79% | -3470.49% | -3588.03% | -3179.64% |
| Gross Profit Growth % | 99.94% | 100% | -58.25% | -134.2% | -129% | -173.18% | -147.61% | -8.34% | -6.98% | 35.54% | 44.83% | -731.37% |
| Operating Expenses | 105.86M | 97.04M | 12.56M | 13.06M | 13.92M | 15.13M | 15.26M | 10.59M | 15.33M | 9.93M | 8.72M | 10.13M |
| OpEx % of Revenue | - | - | - | - | - | 202.75% | 5051.66% | 2964.99% | 3557.54% | 1928.74% | 1864.1% | 1296.67% |
| Selling, General & Admin | 27.87M | 19.54M | 12.56M | 13.06M | 13.92M | 15.13M | 15.26M | 10.59M | 15.33M | 9.93M | 8.72M | 10.13M |
| SG&A % of Revenue | - | - | - | - | - | 202.75% | 5051.66% | 2964.99% | 3557.54% | 1928.74% | 1864.1% | 1296.67% |
| Research & Development | 77.99M | 77.51M | 65.8M | 63.01M | 60.81M | 56.29M | 41.88M | 27.26M | 26.98M | 18.39M | 17.26M | 25.61M |
| R&D % of Revenue | - | - | - | - | - | 754.23% | 13867.88% | 7635.85% | 6260.79% | 3570.49% | 3688.03% | 3279.64% |
| Other Operating Expenses | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -105.86M | -97.04M | -78.36M | -76.07M | -74.73M | -63.96M | -56.84M | -37.49M | -41.89M | -27.81M | -25.52M | -34.96M |
| Operating Margin % | - | - | - | - | - | -856.97% | -18819.54% | -10500.84% | -9718.33% | -5399.22% | -5452.14% | -4476.31% |
| Operating Income Growth % | -41.66% | -51.74% | -37.87% | -102.91% | -78.41% | -130.01% | -122.74% | -7.23% | -9.96% | 32.92% | 42.39% | 42.11% |
| EBITDA | -105.82M | -97.02M | -78.34M | -76.02M | -74.68M | -63.91M | -56.74M | -37.38M | -41.77M | -27.7M | -25.41M | -34.85M |
| EBITDA Margin % | - | - | - | - | - | -856.34% | -18789.07% | -10470.87% | -9692.34% | -5377.67% | -5428.85% | -4462.74% |
| EBITDA Growth % | -41.7% | -51.8% | -38.06% | -103.37% | -78.77% | -130.76% | -123.34% | -7.25% | -9.98% | 33.02% | 42.5% | 42.18% |
| D&A (Non-Cash Add-back) | 39K | 28K | 19K | 46K | 47K | 47K | 92K | 107K | 112K | 111K | 109K | 106K |
| EBIT | -105.86M | -97.04M | -73.93M | -76.07M | -74.73M | -63.96M | -56.84M | -37.49M | -41.89M | -27.81M | -25.52M | -34.96M |
| Net Interest Income | 13.3M | 0 | 0 | 4.94M | 0 | 0 | 0 | 0 | 0 | 822K | 884K | 648K |
| Interest Income | 13.3M | 0 | 0 | 4.94M | 0 | 0 | 0 | 0 | 0 | 928K | 884K | 648K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 106K | 0 | 0 |
| Other Income/Expense | 13.3M | 8.13M | 4.42M | 4.94M | 5.43M | 5.28M | 4.92M | 4.81M | 2.33M | 928K | 884K | 648K |
| Pretax Income | -92.56M | -88.91M | -73.93M | -71.13M | -69.3M | -58.68M | -51.91M | -32.68M | -39.55M | -26.88M | -24.63M | -34.31M |
| Pretax Margin % | - | - | - | - | - | -786.27% | -17188.74% | -9153.22% | -9177.03% | -5219.03% | -5263.25% | -4393.34% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -92.56M | -88.91M | -73.93M | -71.13M | -69.3M | -58.68M | -51.91M | -32.68M | -39.55M | -26.88M | -24.63M | -34.31M |
| Net Margin % | - | - | - | - | - | -786.27% | -17188.74% | -9153.22% | -9177.03% | -5219.03% | -5263.25% | -4393.34% |
| Net Income Growth % | -33.57% | -51.52% | -42.43% | -117.67% | -75.2% | -118.32% | -110.74% | 4.77% | -5.6% | 34.72% | 43.95% | 43% |
| Net Income (Continuing) | -92.56M | -88.91M | -73.93M | -71.13M | -69.3M | -58.68M | -51.91M | -32.68M | -39.55M | -26.88M | -24.63M | -34.31M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.20 | -3.50 | -3.36 | -3.31 | -3.29 | -2.94 | -2.75 | -1.74 | -2.84 | -2.97 | -2.72 | -7.38 |
| EPS Growth % | 2.74% | -19.05% | -22.18% | -90.23% | -15.85% | 1.01% | -1.1% | 76.42% | 73.16% | 76.96% | 80.97% | 62.65% |
| EPS (Basic) | -3.20 | -3.52 | -3.36 | -3.31 | -3.29 | -2.94 | -2.75 | -1.74 | -2.84 | -2.97 | -2.72 | -7.38 |
| Diluted Shares Outstanding | 28.88M | 22.5M | 21.98M | 21.47M | 21.06M | 19.98M | 18.88M | 18.82M | 13.9M | 9.06M | 9.04M | 4.65M |
| Basic Shares Outstanding | 28.88M | 22.5M | 21.98M | 21.47M | 21.06M | 19.98M | 18.88M | 18.82M | 13.9M | 9.06M | 9.04M | 4.65M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |